Difenidol or diphenidol

A benzoylguanidine compound that selectively inhibits NHE-1 (IC₅₀s range from 0.03-3.4 &microM).

A fluorogenic probe that acts as a substrate for specific cytochrome P450 (CYP) isoforms, including CYP3A4, CYP2C8, CYP2C9, CYP2C19, and aromatase (CYP19) used to detect changes in CYP catalytic activity caused by drugs or disease.

A type A trichothecene mycotoxin.

A 2,6-disubstituted purine derivative that causes dedifferentiation of cultured myoblasts into confluent stem cell progenitors.

A benzoylguanidine compound that selectively inhibits NHE-1 (IC₅₀s range from 0.03-3.4 &microM).

An anti-epileptic drug that inhibits the synaptosomal uptake of GABA, increasing the activation of GABAA receptors inhibits CYP3A4, CYP1A2, and CYP2C19 inhibits LDH, blocking both lactate-to-pyruvate and pyruvate-to-lactate conversions by human

An isomer of cyclosporin A that forms upon acid hydrolysis or upon ionization during MS.

A stable, monomethoxylated resveratrol derivative that at 0.1-10 &muM reduces neurotoxicity in SH-SY5Y cells induced by the parkinsonian mimetic 6-OHDA and scavenges DPPH radicals (IC₅₀ = 47.1 &muM).

A common by-product of the Wittig reaction useful as a standard in analyzing products of synthetic routes that utilize the Wittig reaction.

A non-selective mACh receptor antagonist and non-specific inhibitor of voltage-gated ion channels in neurons used to study animal models of vertigo and emesis.

A 2,6-disubstituted purine derivative that causes dedifferentiation of cultured myoblasts into confluent stem cell progenitors.

An anti-epileptic drug that inhibits the synaptosomal uptake of GABA, increasing the activation of GABAA receptors inhibits CYP3A4, CYP1A2, and CYP2C19 inhibits LDH, blocking both lactate-to-pyruvate and pyruvate-to-lactate conversions by human